4//SEC Filing
Huntsman Ronald Kirk 4
Accession 0001493152-24-048026
CIK 0001716166other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 4:47 PM ET
Size
7.5 KB
Accession
0001493152-24-048026
Insider Transaction Report
Form 4
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2024-11-26$2.64/sh+315,421$832,711→ 364,755 totalExercise: $2.64Exp: 2034-09-07→ Common Stock (315,421 underlying)
Holdings
- 3,461
Common Stock
- 69,600(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by Coronado V Partners, LLC, of which the Reporting Person is a member and manager.
- [F2]On September 7, 2024 (the "Grant Date"), the Reporting Person received a grant of 315,421 stock options, which grant was made under but subject to stockholder approval of the Issuer's 2024 Omnibus Equity Incentive Plan and such grant at the Issuer's 2024 Annual Meeting. Such meeting was held, and such stockholder approval was obtained, on November 26, 2024. One-third shall vest and become exercisable in three installments on each of the first, second and third anniversaries of the date of grant through September 7, 2027.
Documents
Issuer
Vivos Therapeutics, Inc.
CIK 0001716166
Entity typeother
Related Parties
1- filerCIK 0001835498
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 4:47 PM ET
- Size
- 7.5 KB